Contact
Please use this form to send email to PR contact of this press release:
European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma
TO:
Please use this form to send email to PR contact of this press release:
European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma
TO: